Benjamin Gerendash

Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA

N. Agarwal, A. Bryce, O. Sartor, 2020, Journal for ImmunoTherapy of Cancer.

Advances in treatment of metastatic renal cell carcinoma

S. Pal, J. Gong, N. Dizman, 2016, Current opinion in urology.

Practical management of adverse events associated with cabozantinib treatment in patients with renal-cell carcinoma

P. Creel, Benjamin Gerendash, 2017, OncoTargets and therapy.